Commercial Strategy

A digital health product only succeeds if it can prove it works, and prove it is worth paying for. ETHOS helps you build the commercial case, so your product can demonstrate both clinical value and economic value to the people who commission, reimburse and buy it.

We work alongside your clinical team or Contract Research Organisation to define the product claims your evidence needs to support, then help you build the case behind them. That includes a Cost-Effectiveness Dossier setting out the long-term economic benefits that matter for reimbursement and tenders, and the core evidence documents that underpin it: Health Technology Assessment, Willingness to Pay analysis, and a Market Penetration Strategy to shape your trial objectives from the outset.

Our Market Access Strategy then addresses how your product reaches the market: reimbursement and tender routes, the country-specific differences that affect them, and the role of Group Purchasing Organisations. The result is a go-to-market approach where the clinical evidence and the commercial strategy support each other, rather than being built in isolation.

Because our commercial advice sits alongside our work in safety, security and effectiveness, we can connect your route to market with the compliance your product has to meet, so the same product that proves its commercial value also meets the standards the market expects.

 

For more information or to discuss your early-stage project confidentially, please contact us.